Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Indivior Plc LSE:INDV London Ordinary Share GB00BRS65X63 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.20 -1.5% 144.90 144.80 145.00 146.90 144.70 146.00 141,653 10:15:14
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 473.2 -126.5 -14.6 - 1,064

Indivior Share Discussion Threads

Showing 3576 to 3599 of 3750 messages
Chat Pages: 150  149  148  147  146  145  144  143  142  141  140  139  Older
DateSubjectAuthorDiscuss
27/11/2020
11:50
Sprry to holders here but can see more than 50 down today
marmar80
27/11/2020
11:46
If they log this claim and win. INDV is done right? They'd be in the negative.
genierub
27/11/2020
11:46
I suspect Indivior will make a counterclaim .....at the end of the day only the lawyers will make money.
steeplejack
27/11/2020
11:46
back in 2019 when the DoJ lawsuit was announced the comp never mentionedvthe 3 billion being sought. That ended up in a news article. Only those that saw the news article had the full picture
dealy
27/11/2020
11:44
Yes bizarre and amateurish.They've left the market hanging for further info.Given the claim was filed two weeks ago and its only just been picked up,you'd think the company might ring their old parent RB and ask for an explanation before screwing up their own share price.
steeplejack
27/11/2020
11:40
If they were you'd think they say something in the rns to stop the huge fall that was coming. That rns was useless. No reassurance or anything.
babbler
27/11/2020
11:38
Yes that's how I read it but actually I'm not sure that Indivior won't make a counter claim.
steeplejack
27/11/2020
11:35
When lawyers start salivating,you know it's time to worry.I can't believe that RB intends to bankrupt its offshoot but we need to know exactly what RB's intention is.
steeplejack
27/11/2020
11:35
it would mean the current shareholders have to pay RB's bill
dealy
27/11/2020
11:34
That's basically the whole company
babbler
27/11/2020
11:32
it never ends, the drama with this company
dealy
27/11/2020
11:22
Does the parent wish to strangle her child?RNS Number : 7714GIndivior PLC27 November 2020Claim filed by Reckitt Benckiser Group plcIndivior PLC (the 'Company') has been made aware that a claim was submitted to the Commercial Court in London by Reckitt Benckiser Group plc ('RB') against the Company on November 13, 2020 pursuant to an indemnity contained in the Demerger Agreement entered into between RB and the Company on November 17, 2014. The amount claimed under the submission is GBP1,073,622.580.51.The claim has not been served on the Company and the Company does not have any further details at this time. The Company will assess with its advisors the background and merits to the case and will provide an update in due course.ENDS
steeplejack
23/11/2020
11:47
(INDV) London Stock Exchange Share Price: 131.50 Bid: 131.30 Ask: 131.60 Change: 0.40 (0.31%)
adrian j boris
22/11/2020
13:32
RNS Number : 0258G Indivior PLC 20 November 2020 Indivior PLC - Appointment of Chief Financial Officer Slough, UK, and Richmond, VA, November 20, 2020 - The Board of Directors of Indivior PLC are pleased to announce the appointment of Ryan Preblick as Chief Financial Officer and Executive Director with immediate effect. Ryan has been serving as Interim Chief Financial Officer since June 2020 and has been in financial leadership roles since joining Indivior in 2012. Prior to his appointment as Interim Chief Financial Officer in June 2020, Ryan was Senior Vice President, Global Financial Planning and Analysis Commercial Operations. This role included overseeing all key financial management, analysis and reporting elements of the Group's global business. Prior to that, Ryan was Vice President, US Finance with responsibility overseeing all financial areas of the US business, the Group's largest business, including management, planning, analysis and reporting, government pricing and managed care contracting operations. Ryan started his career in corporate finance at Honeywell International and then spent twelve years at Altria Company (including Philip Morris USA) in finance leadership roles of increasing responsibility working with Treasury, Financial Planning & Analysis, Market Analytics, Supply Chain and Brand Decision Support. Ryan holds a BS in Finance from Penn State University and an MBA from the University of Richmond. Comment by Mark Crossley, Chief Executive Officer Ryan has proven to be a highly capable leader of our finance organization and has performed strongly in his role as Interim Chief Financial Officer. The Board and I are delighted to confirm his appointment as Chief Financial Officer and Executive Director. The Company confirms there is no further information to be disclosed pursuant to LR 9.6.13 in connection with Ryan Preblick's appointment. About Indivior Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 700 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior . Investor Contact : Jason Thompson, Indivior Vice President, Investor Relations +1 804-402-7123 Jason.Thompson@indivior.com Media Contacts : UK Tulchan Communications +44 207-353-4200 US IndiviorMediaContacts@indivior.com +1 804-594-0836 -ends-
the grumpy old men
19/11/2020
22:50
129.95 GBX +0.19%
waldron
19/11/2020
09:27
Https://www.marketscreener.com/quote/stock/INDIVIOR-19344116/ Looking good, so perhaps a chance that share price soon approaches the 142.40p resistence
waldron
19/11/2020
09:24
Price (GBX) 130.20 0.39% (0.50) INDVORD USD0.10 Track 1 instrument Open / Last close 129.40 / 129.70 High / Low 130.60 / 128.20 Bid / Offer 130.00 / 130.30 Special Condition: - Trading Status: Regular Trading FTSE 250 As at 19.11.20 09:07:13 - All data delayed at least 15 minutes
waldron
18/11/2020
19:24
Yesterday’s Jeffries virtual conference had Mark Crossley the new CEO of Indivior outlining the company’s position. He was very positive and I thought he gave an encouraging message for the company’s prospects. Time will tell, of course, but I liked the message
gregmorg
18/11/2020
16:42
Price (GBX) 130.90 4.72% (5.90) Open / Last close 127.60 / 125.00 High / Low 134.30 / 125.20 Bid / Offer 130.80 / 131.00 Special Condition: - Trading Status: Regular Trading FTSE 250 As at 18.11.20 16:26:31 - All data delayed at least 15 minutes
ariane
14/11/2020
04:59
Price (GBX) 125.00 1.63% (2.00) Open / Last close 122.70 / 125.00 High / Low 125.00 / 120.50 Bid / Offer 123.60 / 123.90 Special Condition: - Trading Status: Market Close FTSE 250 As at 14.11.20 04:42:58 - All data delayed at least 15 minutes
ariane
14/11/2020
04:57
HOME > Latest > Indivior sinks as settlement confirmed Indivior sinks as settlement confirmed By Master Investor 13 November 2020 0 mins. to read Indivior sinks as settlement confirmed FTSE 250 pharmaceuticals firm Indivior (LON:INDV) saw its share price drop by 1.79% to 120.80p (as of 11:55 GMT) after a US federal court approved the agreement between the firm and the Department of Justice. Under the terms of the agreement, the company will pay $600 million over seven years and all charges brought by grand jury due to a subsidiary’s false statements will be dismissed. Management said they were pleased to put this matter behind them and to allow the company to move ahead with certainty.
ariane
13/11/2020
10:18
Good to see the Court confirmation. It takes time for investors to put these shocks behind them and nervousness is likely to remain apparent, albeit hopefully diminishing. Lets see whether the company can do its bit and grow profitably from here.
gregmorg
13/11/2020
08:48
Indivior Happy To Put Suboxone Matter Behind It As Court Approves Deal Fri, 13th Nov 2020 08:19 Alliance News (Alliance News) - Indivior PLC said Friday a US federal court in the Western District of Virginia has approved the agreement between the pharmaceuticals firm and the US Department of Justice over resolving criminal charges in the US related to its Suboxone film opioid dependence medication. In mid-July, Indivior agreed to part with USD600 million to resolve the charges with the US Justice Department. In April 2019 a grand jury in the Western District of Virginia had issued an indictment of 28 felony counts against the company related to fraud. The felonies, issued in connection with a federal criminal investigation initiated by the US Department of Justice in 2013, include one count of conspiracy to commit mail, wire and health care fraud; one count of health care fraud; four counts of mail fraud; and 22 counts of wire fraud. In a statement Friday, Indivior noted the federal court has dismissed all of these charges. Indivior could have faced USD3 billion in fines related to the matters. "As previously noted, Indivior is pleased to put this matter behind it and move forward in a manner that provides certainty to its business," the firm said Friday. Previously, Indivior Solutions Inc, a wholly-owned subsidiary of Indivior PLC, pleaded guilty to one count of making a false statement relating to health care matters in 2012. As a result Indivior Solutions is now excluded from participating in US government health schemes, though the ban will not affect other Indivior subsidiaries. Shares in Indivior were down 0.3% in London on Friday morning at 122.60 pence each. By Paul McGowan; paulmcgowan@alliancenews.com
grupo guitarlumber
13/11/2020
08:19
RNS Number : 1999F Indivior PLC 13 November 2020 US Court Approval of Agreement with Justice Department Slough, United Kingdom and Richmond, Virginia - November 13, 2020 - Indivior PLC (LON: INDV) announced that a United States federal court in the Western District of Virginia has approved the agreement between the Group and the U.S. Department of Justice and other government agencies that was announced on July 24. The court has also dismissed all charges that were returned by a grand jury in April 2019. As previously noted, Indivior is pleased to put this matter behind it and move forward in a manner that provides certainty to its business.
grupo guitarlumber
Chat Pages: 150  149  148  147  146  145  144  143  142  141  140  139  Older
ADVFN Advertorial
Your Recent History
LSE
INDV
Indivior
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210513 09:32:09